Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krisztina B Gecse

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
The Lancet. Gastroenterology & Hepatology|August 14, 2018
Differential diagnosis of inflammatory bowel disease: imitations and complicationsKrisztina B Gecse, Severine Vermeire
Current Drug Targets|May 23, 2019
Implication of Medical Treatment for Surgical Strategies in IBDKrisztina B Gecse, Christianne J Buskens
Drugs|September 18, 2016
Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future ProspectsKrisztina B Gecse, Péter L Lakatos
Gastroenterology|February 15, 2022
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future PerspectivesPeter M Irving, Krisztina B Gecse
Expert Opinion on Pharmacotherapy|May 20, 2014
Ulcerative proctitis: an update on the pharmacotherapy and managementKrisztina B Gecse, Peter L Lakatos
Diseases of the Colon and Rectum|November 20, 2018
Topical Oxymetazoline for Fecal Incontinence in Patients with Spinal Cord Injury: A Double-Blind Randomized Controlled Crossover StudyNir Barak, Krisztina B Gecse, István Takács
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?Krisztina B Gecse, Fraser Cumming, Geert D'Haens
Scandinavian Journal of Gastroenterology|November 14, 2023
Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategiesSuzanne I Anjie, Jurij Hanzel, Krisztina B Gecse, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
AJR. American Journal of Roentgenology|August 2, 2023
Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the <i>AJR</i> Special Series on Imaging of FibrosisJordi Rimola, Kim J Beek, Ingrid Ordás, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
The Lancet. Gastroenterology & Hepatology|August 14, 2018
Differential diagnosis of inflammatory bowel disease: imitations and complicationsKrisztina B Gecse, Severine Vermeire
Current Drug Targets|May 23, 2019
Implication of Medical Treatment for Surgical Strategies in IBDKrisztina B Gecse, Christianne J Buskens
Drugs|September 18, 2016
Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future ProspectsKrisztina B Gecse, Péter L Lakatos
Gastroenterology|February 15, 2022
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future PerspectivesPeter M Irving, Krisztina B Gecse
Expert Opinion on Pharmacotherapy|May 20, 2014
Ulcerative proctitis: an update on the pharmacotherapy and managementKrisztina B Gecse, Peter L Lakatos
Diseases of the Colon and Rectum|November 20, 2018
Topical Oxymetazoline for Fecal Incontinence in Patients with Spinal Cord Injury: A Double-Blind Randomized Controlled Crossover StudyNir Barak, Krisztina B Gecse, István Takács
Expert Review of Gastroenterology & Hepatology|February 23, 2019
Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?Krisztina B Gecse, Fraser Cumming, Geert D'Haens
Scandinavian Journal of Gastroenterology|November 14, 2023
Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategiesSuzanne I Anjie, Jurij Hanzel, Krisztina B Gecse, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
AJR. American Journal of Roentgenology|August 2, 2023
Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the <i>AJR</i> Special Series on Imaging of FibrosisJordi Rimola, Kim J Beek, Ingrid Ordás, et al.
Pageof 9